Summary of NovaBay Pharmaceuticals 2026 Special Meeting Company Overview - **Company Name**: NovaBay Pharmaceuticals, Inc. (NYSEAM:NBY) - **Meeting Date**: March 12, 2026 - **Meeting Type**: Special Meeting of Stockholders Key Points Discussed Meeting Structure - The meeting was presided over by Michael Kazley, CEO and Chairman of the Board, with other board members and guests participating virtually [2][3] - The meeting included a formal session to address official business and a subsequent informal Q&A session [4] Voting Proposals 1. **Private Placement Issuance Proposal** - Approval for the issuance of 837,696,130 shares of common stock upon exercise of pre-funded warrants from the January 2026 private placement [9] - The board recommended approval [11] 2. **October Warrant Share Issuance Proposal** - Approval for the issuance of 5,405,406 shares of common stock upon exercise of pre-funded warrants from October 2025 [12] - The board recommended approval [14] 3. **Written Consent Proposal** - Amendment to the certificate of incorporation to permit stockholder action by written consent [15] - The board recommended approval [16] 4. **Officer Exculpation Proposal** - Amendment to provide for officer exculpation under Delaware law [17] - The board recommended approval [18] 5. **Authorized Common Stock Proposal** - Increase the number of authorized shares of common stock from 1.5 billion to 5.0 billion [19] - The board recommended approval [20] 6. **Equity Incentive Plan Proposal** - Approval of the 2026 equity incentive plan [22] - The board recommended approval [22] Voting Results - A quorum was established with approximately 96.73% of voting power represented [7] - All six proposals were approved by stockholders [24] Additional Important Information - The record date for stockholders entitled to vote was February 10, 2026 [5] - The meeting included a formal voting process where stockholders could vote in person or by proxy [11][20] - The meeting concluded with an invitation for questions from stockholders, indicating a focus on transparency and engagement [25]

Summary of BiomX Inc. Special Meeting of Stockholders Company Overview - **Company**: BiomX Inc. (NYSEAM:PHGE) - **Date of Meeting**: March 11, 2026 - **Key Speakers**: Michael Oster (CEO), David Rokach (CFO) Key Points Discussed Meeting Structure and Attendance - The meeting was called to order by the CEO, Michael Oster, with the presence of CFO David Rokach, both newly appointed executives [2] - A quorum was established with 556,978 shares represented out of 1,593,516 shares outstanding as of February 3, 2026 [3] Agenda Items 1. **Approval of Share Issuance**: - The first order of business was to approve the issuance of shares of common stock underlying Series Y convertible preferred stock and warrants [5] - This issuance is in compliance with Section 713(a) of the NYSE American LLC Company Guide and relates to a security purchase agreement dated December 26, 2025, and an engagement letter dated November 26, 2025 [5][6] - The board recommended a vote in favor of this issuance proposal, which requires a majority vote from shareholders present [6] 2. **Adjournment Proposal**: - The second order of business was to vote on the adjournment of the meeting if necessary to solicit additional proxies for the issuance proposal [7] - This proposal also requires a majority vote from shareholders present, with the board recommending approval [7] Voting Outcomes - Preliminary counts indicated sufficient votes to approve the issuance of shares and to adjourn the meeting if necessary [9] - The issuance of shares was officially declared approved, completing the agenda of the meeting [10] Additional Notes - The meeting included a process for shareholders to vote through a virtual platform, ensuring participation [3][8] - The CEO and CFO expressed their commitment to advancing the company's programs and delivering long-term value to shareholders [2] This summary encapsulates the critical aspects of the special meeting, focusing on the company's governance and shareholder engagement processes.

Group 1 - The core point of the article is that Longpan Technology (龙蟠科技) has received approval from the Shanghai Stock Exchange for its application to issue shares to specific investors, indicating compliance with issuance conditions, listing conditions, and information disclosure requirements [1] Group 2 - The company will submit its application documents to the China Securities Regulatory Commission for registration after receiving the approval [1]

Core Viewpoint - The company has received approval from the China Securities Regulatory Commission for the registration of a stock issuance to specific investors [1] Group 1 - The approval is documented in the official notice numbered 217, indicating the company's compliance with regulatory requirements [1] - The company’s board of directors will proceed with the stock issuance process within the stipulated timeframe as per the approval and relevant laws [1]

Core Viewpoint - The announcement from 易思维 (688816.SH) indicates the final distribution of shares after the activation of the allocation mechanism, highlighting the proportions of offline and online issuances [1] Group 1: Share Distribution - The final number of shares issued offline is 12.482018 million shares, accounting for 60.78% of the total issuance after deducting the final strategic placement [1] - The final number of shares issued online is 8.0540 million shares, representing 39.22% of the total issuance after deducting the final strategic placement [1] - The overall total issuance amounts to 24.999999 million shares, with offline and online distributions making up 49.93% and 32.22% of this total, respectively [1] Group 2: Subscription Rate - The final online subscription rate is 0.02220760%, indicating a low probability of successful allocation for online investors [1]

Core Viewpoint - The market's sell-off of Oracle (ORCL.N) may have been excessive, but concerns about the company's future remain valid [1] Group 1: Financial Position - The company is in a precarious situation, needing to perform exceptionally well to overcome its challenges [1] - Oracle has $130 billion in debt and $248 billion in operating lease commitments, which will burden the company in the coming years [1] Group 2: Market Impact - The planned stock issuance by the company may create additional selling pressure in the market over the next 10 weeks [1]

Group 1 - The company, Guangdian Measurement Testing Group Co., Ltd., has completed the filing of its 2025 A-share issuance report for specific targets and main board listing with the Shenzhen Stock Exchange [1] - The company assures that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1] - The company will proceed with the registration and custody of the newly issued shares in accordance with relevant regulations [1] Group 2 - The issuance report and related documents have been disclosed on the Giant Tide Information Network for investors to review [1]

Financial Data and Key Metrics Changes - The stockholders approved the issuance of shares of common stock as part of a merger agreement dated November 2nd, 2025, indicating a strategic move for the company [4][7]. Business Line Data and Key Metrics Changes - No specific data on business line performance or key metrics was provided in the meeting [1]. Market Data and Key Metrics Changes - No specific market data or key metrics were discussed during the meeting [1]. Company Strategy and Development Direction and Industry Competition - The company is pursuing a merger with Kenvue and other entities, which suggests a focus on strategic partnerships to enhance growth and market position [4][5]. Management Comments on Operating Environment and Future Outlook - Management expressed gratitude for stockholder support and indicated a positive outlook following the approval of the issuance proposal, although specific comments on the operating environment were not detailed [9]. Other Important Information - The meeting was conducted virtually, and stockholders were encouraged to submit questions via the meeting portal, with responses to be provided via email after the meeting [3][8]. Summary of Q&A Session - There were no specific questions or answers recorded during the meeting, as the focus was primarily on the approval of the issuance proposal [1].

Core Viewpoint - The company, Muyuan Foods, has announced the issuance of H-shares, with a global offering of 274 million shares and a maximum issuance of 315 million shares, priced at a maximum of HKD 39 per share [2] Group 1 - The H-share public offering in Hong Kong commenced on January 29 and is expected to conclude on February 3, with the issuance price to be announced no later than February 4 [2]

易思维（杭州）科技股份有限公司 首次公开发行股票并在科创板上市 招股意向书提示性公告 扫描二维码查阅公告全文 易思维（杭州）科技股份有限公司（以下简称"易思维"、"发行人"或"公 司"）首次公开发行股票并在科创板上市的申请已经上海证券交易所（以下简称 "上交所"）上市审核委员会审议通过，并已经中国证券监督管理委员会（以下 简称"中国证监会"）同意注册（证监许可〔2025〕2791 号）。《易思维（杭州） 科技股份有限公司首次公开发行股票并在科创板上市招股意向书》及附录在上海 证券交易所网站（http://www.sse.com.cn）和符合中国证监会规定条件网站（中国 证券报：https://www.cs.com.cn；上海证券报：https://www.cnstock.com；证券时报： http://www.stcn.com；证券日报：http://www.zqrb.cn）披露，并置备于发行人、上 交所、本次发行保荐人（主承销商）国投证券股份有限公司的住所，供公众查阅。 （此页无正文，为《易思维（杭州）科技股份有限公司首次公开发行股票并在 科创板上市招股意向书提示性公告》盖章页） 发行人： 易思维（杭州） ...